CALL US TODAY FOR A FREE CONSULTATION: 800.545.3737 - 617.742.1900|ATTORNEY@SWARTZLAW.COM
Home/Tag: FDA

Leading baby food manufacturers knowingly sold products with high levels of toxic metals, a congressional investigation found

Four leading baby food manufacturers knowingly sold baby food that contained high levels of toxic heavy metals, according to internal company documents included in a congressional investigation released Thursday. "Dangerous levels of toxic metals like arsenic, lead, cadmium and mercury exist in baby

Leading baby food manufacturers knowingly sold products with high levels of toxic metals, a congressional investigation found2021-04-16T07:49:12-04:00

Punitive damages in a personal injury case – David Faraci

  Often times personal injury cases have settlements or awards that are given to the plaintiff, after there have been findings of wrongdoing by the defendant. However, there can additional punishments that are handed down towards the defendant if

Punitive damages in a personal injury case – David Faraci2021-03-24T08:49:13-04:00

Zantac Heartburn FDA Recall – Laura Daly

  Swartz and Swartz is currently reviewing cases on behalf clients who have developed cancer as a side effect from using the heartburn drug Zantac. 4 decades after it was approved, the FDA has order Zantac and its generics

Zantac Heartburn FDA Recall – Laura Daly2021-04-16T14:46:16-04:00

FDA Requests Removal of All Ranitidine Products (Zantac) from the Market

The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately.   This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly known by

FDA Requests Removal of All Ranitidine Products (Zantac) from the Market2021-04-16T13:28:40-04:00

The Impact of E-Cigarettes on the Lung

E-cigarettes are a relatively new tobacco product that have been sold in the U.S. for about a decade The e-cigarettes currently in the U.S. marketplace have not been systemically reviewed by the Food and Drug Administration to determine their impact on lung health. While much

The Impact of E-Cigarettes on the Lung2021-04-16T06:07:09-04:00

Compounding Pharmacy Update

According to the Boston Globe, on at least two occasions in the past decade, Massachusetts pharmacy officials have displayed indifference in their supervision of a concerning Framingham compounding pharmacy (The New England Compounding Center) that is linked to the nationwide meningitis outbreak that has killed

Compounding Pharmacy Update2021-04-16T05:57:24-04:00

Meningitis Sister Company Issues Massive Product Recall

The sister company of Framingham’s New England Compounding Center (NECC) – Ameridose – recalled all of its products on October 31, 2012. According to health officials, the NECC is the source of fungus-contaminated steroid injections that have killed 28 people and sickened at least 363

Meningitis Sister Company Issues Massive Product Recall2021-04-16T13:28:19-04:00

More Drugs May Be Linked to U.S. Meningitis Outbreak

On Monday, October 15, U.S. health regulators announced that two other drugs produced by the New England Compounding Center (NECC), of Framingham, Massachusetts, may be linked to the meningitis outbreak.   According to the Food and Drug Administration (FDA), there is an ongoing investigation of

More Drugs May Be Linked to U.S. Meningitis Outbreak2021-04-16T13:38:39-04:00

Framingham pharmacy may be source of fungal meningitis outbreak blamed for 4 deaths

Massachusetts and federal health officials have reportedly identified a Framingham pharmacy as the source of injectable steroids that may have infected more than 25 people, four fatally, with a rare form of fungal meningitis.   The pharmacy, New England Compounding Center, recalled three lots of

Framingham pharmacy may be source of fungal meningitis outbreak blamed for 4 deaths2021-04-16T15:23:43-04:00
Go to Top